{"nct_id":"NCT02927925","title":"A Study to Assess the Clinical Efficacy and Safety of Daratumumab in Participants With Relapsed or Refractory Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type","status":"COMPLETED","status_verified_date":"2020-12","start_date":"2017-02-14","start_date_type":"ACTUAL","primary_completion_date":"2020-01-02","primary_completion_date_type":"ACTUAL","completion_date":"2020-01-07","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}